The Aggregated Misfolded Protein diseases include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).

Download our Updated Corporate Presentation

June 24, 2009:
AMORFIX TEST FOR vCJD ACHIEVES 100% SPECIFICITY ON 20,000 BLOOD DONATIONS IN FRANCE
Download the PDF

June 17, 2009:
Amorfix Licenses Novel Theranostic Platform - PROMIS ™
Download the PDF

June 11, 2009:
Amorfix Anounces 2009 Year End Results
Download the PDF

May 20, 2009:
Press Release Blood Transfusion Service in France Completes 20,000 Tests and Establishes Amorfix EP-vCJD™ Test in a Second Blood Center

April 29, 2009:
Press Release Amorfix Closes $3.3 Million Private Placement

April 24, 2009:
Press Release Amorfix Announces Private Placement

April 23, 2009:
Press Release Amorfix and BioMosaics Collaborate to Develop a Blood Test for Liver Cancer Supported by Grant from the Ontario Institute for Cancer Research

April 20, 2009:
Press Release Amorfix Corporate Update: AMF Expands Diagnostic and Therapeutic Focus to Include Misfolded Protein Diseases Including Cancer

March 18, 2009:
Link to UK NHS Blood and Transplant Tender

February 23, 2009:
Report of Independent Public Inquiry into contaminated blood and blood products
Chaired by the Rt Hon Lord Archer of Sandwell Q.C.

February 16, 2009
View BBC Newsnight Feature:
'Mad Cow Disease' Risk from Donated Blood
Includes clips of Interview with Dr. George Adams and footage from Amorfix Facilites

January 20, 2009:
Press Release Amorfix Awarded 'Life Science Company of the Year'
for Moving Innovative Products into Commercialization

January 13, 2009:
Press Release Large-Scale Testing Initiated in France with 10,000 Blood Samples
Tested for vCJD
- Amorfix Demonstrates vCJD Test Can Be Used Routinely to Test Blood Donations-

December 19, 2008:
Press Release Blood Test for vCJD Achieves 100% Accuracy
- Available For Large-scale Testing of Populations to Identify Infected Carriers -